(Moscow, 25 March 2008) Quantum Pharmaceuticals entered a collaboration with Otechestvennye Lekarstva OJSC. Under the terms of collaborative agreement Quantum Pharmaceuticals will apply its proprietary technology to explore the mechanism of action and new therapeutic uses of several compounds of Otechestvennye Lekarstva OJSC. Quantum Pharmaceutical will utilize its proprietary protein panel representative for human proteome. The financial terms of the agreement were not disclosed.
About Quantum Pharmaceuticals
Quantum Pharmaceuticals is a drug discovery company based in Moscow, Russia specializing in small molecule screening and design through the use of its proprietary technology platform.
About Otechestvennye Lekarstva OJSC
Otechestvennye Lekarstva OJSC is one of the largest Russian pharmaceutical companies with recent turnover of US$150 million. The company has 5,000 employees and markets over 200 products in Russia and in 20 other countries. Otechestvennye Lekarstva OJSC was selected as the best pharmaceutical company in Russia in 2005 and 2006 by the Russian government.
Related posts:
- Quantum Pharmaceuticals and Institute of Pulmonology entered COPD drug discovery collaboration.
- Quantum Pharmaceuticals and Tibotec Pharmaceuticals enter antiviral drug discovery collabortaion.
- HIV-1 integrase drug discovery collaboration
- Quantum Pharmaceuticals and MOLECMO Nanobiotechnologies announce collaboration.
- EMD Serono, Inc licensed Quantum Pharmaceuticals’ drug discovery technology.
